Citius Pharmaceuticals Inc vs Twilio Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Twilio Inc trades at $254 (market cap $39.31B). The key difference: Twilio Inc is far larger — about 1964.5× Citius Pharmaceuticals Inc's market cap, and Twilio Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | TWLO | |
|---|---|---|
Market Cap | $20.01M | $39.31B |
Sector | Health | Technology |
52-Week High | $1.82 | $255.95 |
52-Week Low | $0.48 | $95.23 |
Enterprise Value | $16.23M | $37.72B |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →